Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Thu, 29.02.2024
R. STAHL AG
Several structural trends could drive mid-term growth
Topic: Despite a strong competitive quality, R. Stahl had difficulties
translating it into operating performance between 2016 and 2021. Thanks to
R. Stahl having done its homework by implementing changes on the back of
efficiency and structural trends kicking in, shares look poised for a
re- [ … ]
Wed, 28.02.2024
KORREKTUR: Rubean AG
KORREKTUR: Major cooperation with Global Payments in Germany; chg.
Topic: Yesterday, Rubean announced to have won the Global Payments tender
for Germany, which we assume to be basically the tender for the recently
announced joint venture between Commerzbank and Global Payments (“Commerz
Globalpay”). In detail:
Earlier this year, C [ … ]
Wed, 28.02.2024
LAIQON AG
Game changing cooperation with Union Investment; chg
Recently, LAIQON has announced to have closed the game changing cooperation
with Union Investment. With that, LAIQON provided a new promising guidance
for its subsidiary LAIC, mainly reflecting the potential of the new
cooperation. Further, LAIQON announced a capital raise on the level of LAI [ … ]
Wed, 28.02.2024
beaconsmind AG
Strong order intake to start the year; chg.
Topic: beaconsmind announced three major contract extensions, two of which
in the CloudWiFi hotspot segment, proving the strength of the groups newly
aligned product portfolio. In detail:
The company extended its collaboration with nursing homes operator Vitanas,
where beaconsmind will implement com [ … ]
Wed, 28.02.2024
CLIQ Digital AG
Solid FY figures & sizable share buyback; est. & PT chg.
Topic: CLIQ reported final FY23 figures on Thursday (update on prelims from
Feb. 5th) and announced a € 13m share repurchase program. Here are our key
takeaways:
Strong bundled content share boosts higher-LTV customer base. At 94% of
FY23 total revenues (88% in FY22), bundl [ … ]
Wed, 28.02.2024
Rubean AG
Major cooperation with Commerz Globalpay; chg.
Topic: Yesterday, Rubean announced to have won the Global Payment tender
for Germany, which is basically the tender for the recently announced joint
venture between Commerzbank and Global Payments (“Commerz Globalpay”). In
detail:
Earlier this year, Commerzbank announced to have enter [ … ]
Tue, 27.02.2024
Valneva
First Berlin Equity Research has published a research update on Valneva SE
(ISIN: FR0004056851). Analyst Simon Scholes reiterated his BUY rating and
decreased the price target from EUR 8.90 to EUR 8.60.
Abstract:
FY/23 product revenues recovered strongly (+26% to €144.6m) in line with
resurgent travel activity. The current cash position is [ … ]
Tue, 27.02.2024
Cardiol Therapeutics Inc
First Berlin Equity Research has published a research update on Cardiol
Therapeutics Inc. (ISIN: CA14161Y2006). Analyst Christian Orquera
reiterated his BUY rating and maintained his USD 3.60 price target.
Abstract:
Cardiol Therapeutics (Cardiol) announced that the FDA has granted Orphan
Drug Designation (ODD) in the US for its lead drug candid [ … ]
Mon, 26.02.2024
Schloss Wachenheim
First Berlin Equity Research has published a research update on Schloss
Wachenheim AG (ISIN: DE0007229007). Analyst Simon Scholes reiterated his
BUY rating and maintained his EUR 22.00 price target.
Abstract:
Although inflation is falling and wage and salary increases are partially
compensating for lost consumer purchasing power, the business e [ … ]
Mon, 26.02.2024
Vectron Systems AG
Preliminary figures for 2023: Sales and earnings development in line with
expectations, rating: BUY
Vectron Systems AG (Vectron for short) published its preliminary figures
for the past fiscal year 2023 on 21 February 2024. With sales revenue of €
37.4 million (previous year: € 25.2 million), the company not only
significantly ex [ … ]